Hospital
Palestine Principal Healthcare Limited Partnership
Palestine Principal Healthcare Limited Partnership was paid $6.80M by Medicaid between Jul 2020 and Nov 2024, across 80 billing codes. Its largest line is 99284, emergency room visit (serious) — 40% of everything it billed.
33Billing provider infoPALESTINE PRINCIPAL HEALTHCARE LIMITED PARTNERSHIP
PALESTINE, TX 75801
PALESTINE, TX 75801
33aNPI1164510673assigned 10/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.80M
24GClaims97,899
24DCodes billed80
24AFirst – last monthJul 2020 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#24 of 109
Median peer was paid$1.15M
This provider vs. median5.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,282 | $71K | |
| 2021 | 21,989 | $940K | |
| 2022 | 32,946 | $1.79M | |
| 2023 | 29,887 | $2.56M | |
| 2024incomplete | 11,795 | $1.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 40% | 9,063 | 8,555 | $2.72M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 12,245 | 11,884 | $1.55M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.9% | 1,399 | 1,270 | $335K |
| 87400 | 4.3% | 5,370 | 5,018 | $295K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.7% | 2,919 | 2,857 | $249K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.6% | 5,973 | 5,786 | $248K |
| 71045 | Radiologic examination, chest; single view | 3.4% | 2,341 | 2,149 | $231K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 5,820 | 5,661 | $149K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.7% | 2,192 | 1,969 | $118K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 706 | 696 | $100K |
| 80053 | Comprehensive metabolic panel | 1.2% | 6,180 | 5,535 | $79K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,846 | 6,079 | $66K |
68 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 83 | $65K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 684 | $63K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,117 | $60K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,569 | $56K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,290 | $52K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,448 | $41K |
| 87807 | <1% | 1,387 | $40K | |
| 87081 | <1% | 2,418 | $32K | |
| 83498 | <1% | 499 | $27K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 243 | $23K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 413 | $21K |
| 83021 | <1% | 502 | $18K | |
| 82261 | <1% | 499 | $17K | |
| 81025 | <1% | 1,220 | $17K | |
| 81001 | <1% | 3,923 | $15K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 901 | $12K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 98 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 170 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 74 | $7K |
| 84484 | <1% | 1,089 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 734 | $6K |
| 84030 | <1% | 501 | $5K | |
| 83690 | <1% | 552 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 280 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 100 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 805 | $4K |
| 82550 | <1% | 759 | $3K | |
| 82150 | <1% | 329 | $3K | |
| 83605 | <1% | 459 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 491 | $3K |
| 81003 | <1% | 882 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 204 | $2K |
| 82247 | <1% | 230 | $2K | |
| 82553 | <1% | 453 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 58 | $2K |
| 83735 | <1% | 562 | $2K | |
| 87040 | <1% | 300 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 292 | $1K |
| 80061 | Lipid panel | <1% | 81 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 225 | $1K |
| 83655 | <1% | 39 | $991.40 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 111 | $477.38 |
| 0011A | <1% | 126 | $410.56 | |
| 0031A | <1% | 41 | $392.22 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 98 | $340.92 |
| 84100 | <1% | 162 | $331.74 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $308.30 |
| 84702 | <1% | 20 | $298.80 | |
| 85027 | <1% | 128 | $260.97 | |
| 86850 | <1% | 18 | $200.14 | |
| 87077 | <1% | 54 | $158.77 | |
| 85018 | <1% | 44 | $135.41 | |
| 85610 | <1% | 75 | $125.29 | |
| 86140 | <1% | 79 | $111.05 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 19 | $107.54 |
| 85730 | <1% | 43 | $81.88 | |
| 36416 | <1% | 1,408 | $77.98 | |
| 86901 | <1% | 36 | $71.04 | |
| 86900 | <1% | 36 | $71.04 | |
| 85007 | <1% | 38 | $52.04 | |
| 82803 | <1% | 15 | $35.71 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24 | $35.30 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,109 | $25.35 |
| 82962 | 0% | 213 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 915 | $0.00 |
| 83880 | 0% | 13 | $0.00 | |
| 91303 | 0% | 16 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRAYLOR, JOHNETTA (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Logan General Hospital LLC | Logan, WV | $43.43M |
| Phc-Cleveland LLC | Cleveland, MS | $23.43M |
| Hartsville, LLC | Hartsville, SC | $18.42M |
| Logan Memorial Hospital LLC | Russellville, KY | $14.29M |
| Southwestern Medical Center, LLC | Lawton, OK | $9.40M |
| Watertown Medical Center LLC | Watertown, WI | $6.31M |
| Amg - Livingston, LLC | Livingston, TN | $5.52M |
| Logan General Hospital LLC | Logan, WV | $4.91M |
| ST. Joseph Hospital LLC | Lewiston, ID | $4.67M |
| Riverton Memorial Hospital LLC | Riverton, WY | $4.65M |
| Livingston Regional Hospital LLC | Livingston, TN | $4.33M |
| Hartsville Medical Group LLC | Hartsville, SC | $4.16M |
| Mexia Principal Healthcare Limited Partnership | Mexia, TX | $2.19M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $1.27M |
| Texas Specialty Physicians | Palestine, TX | $1.26M |
| ST Joseph Hospital LLC | Lewiston, ID | $1.10M |
| Watertown Physician Practices LLC | Watertown, WI | $244K |
| Watertown Physician Practices LLC | Watertown, WI | $175K |
| Amg-Livingston LLC | Livingston, TN | $165K |
| Watertown Physician Practices LLC | Watertown, WI | $149K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.